ASX - By Stock
|
AKP |
Re:
Ann: Suspension from Official Quotation
|
|
Grapire
|
448 |
123K |
7 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
448
|
123K
|
7
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Suspension from Official Quotation
|
|
Grapire
|
448 |
123K |
3 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
448
|
123K
|
3
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Suspension from Official Quotation
|
|
Grapire
|
448 |
123K |
4 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
448
|
123K
|
4
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Suspension from Official Quotation
|
|
Grapire
|
448 |
123K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
448
|
123K
|
1
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Suspension from Official Quotation
|
|
Grapire
|
448 |
123K |
3 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
448
|
123K
|
3
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Preliminary Final Report
|
|
Grapire
|
32 |
7.9K |
4 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
32
|
7.9K
|
4
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Response to ASX Query Letter
|
|
Grapire
|
51 |
11K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
51
|
11K
|
4
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Response to ASX Query Letter
|
|
Grapire
|
51 |
11K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
51
|
11K
|
1
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Response to ASX Query Letter
|
|
Grapire
|
51 |
11K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
51
|
11K
|
0
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Response to ASX Query Letter
|
|
Grapire
|
51 |
11K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
51
|
11K
|
4
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Top-line Results from the Phase 3 AEGIS-II Trial
|
|
Grapire
|
42 |
20K |
0 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
42
|
20K
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano Q2 FY24 Activities Report and Appendix 4C
|
|
Grapire
|
215 |
79K |
9 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
215
|
79K
|
9
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2024 and beyond
|
|
Grapire
|
1.1K |
446K |
7 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
1.1K
|
446K
|
7
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2023 and beyond
|
|
Grapire
|
2.9K |
1.4M |
7 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
2.9K
|
1.4M
|
7
|
|
ASX - By Stock
|
PET |
Re:
PET CLASS ACTION
|
|
Grapire
|
33 |
23K |
2 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
33
|
23K
|
2
|
|
ASX - By Stock
|
MNS |
Re:
Ann: ASIC Supplementary Submission to Senate Inquiry
|
|
Grapire
|
290 |
78K |
4 |
26/08/23 |
26/08/23 |
ASX - By Stock
|
290
|
78K
|
4
|
|
ASX - By Stock
|
MNS |
Re:
Ann: ASIC Supplementary Submission to Senate Inquiry
|
|
Grapire
|
290 |
78K |
3 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
290
|
78K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Grapire
|
116 |
35K |
3 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
116
|
35K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Why a trial?
|
|
Grapire
|
107 |
34K |
2 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
107
|
34K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Grapire
|
15 |
5.8K |
2 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
15
|
5.8K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
1 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
4 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
7 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
11 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
10 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Technical Analysis: 40¢ "GAP" still unfilled...For ones who want to average their buys.
|
|
Grapire
|
33 |
12K |
4 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
33
|
12K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
3 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
3
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Grapire
|
182 |
59K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
182
|
59K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
5 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
4 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
0 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
7 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
10 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
5 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
3 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
3 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
32 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
30 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
9 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
22 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Grapire
|
1.0K |
388K |
24 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Grapire
|
1.3K |
543K |
3 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Grapire
|
1.3K |
543K |
1 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Grapire
|
1.3K |
543K |
4 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Grapire
|
1.3K |
543K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Grapire
|
1.3K |
543K |
1 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Grapire
|
1.3K |
543K |
4 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Time to buy MSB and ride the wave ?
|
|
Grapire
|
144 |
53K |
5 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
144
|
53K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Time to buy MSB and ride the wave ?
|
|
Grapire
|
144 |
53K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
144
|
53K
|
2
|
|